Soft Tissue Evaluation Around Implants Using Prf or a Palatal Pedicle

November 5, 2017 updated by: Andrew George Edward Aziz, Cairo University

Clinical Evaluation of Peri-Implant Soft Tissue Around Immediately Placed Implants Using PRF Membrane Versus The Palatal Pedicle Soft Tissue Graft: A Randomized Controlled Clinical Trial.

Clinical Evaluation of Peri-Implant Soft Tissue Around Immediately Placed Implants Using PRF Membrane Versus The Palatal Pedicle Soft Tissue Graft: A Randomized Controlled Clinical Trial.

Study Overview

Status

Unknown

Detailed Description

Immediate implant will be place and followed by soft tissue augmentation by PRF or palatal pedicle and the primary outcome is the pink esthetic score

Study Type

Interventional

Enrollment (Anticipated)

18

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion criteria

  1. Absence of periodontal disease or a periapical infection
  2. Adequate native bone to achieve implant primary stability
  3. The need for a single-tooth replacement in the anterior maxilla (from the second bicuspid to the second bicuspid), subsequent to an inevitable tooth extraction.

Exclusion criteria

  1. Systemic conditions/disease that contraindicated surgery
  2. Radiation therapy in the head and neck region or chemotherapy during the 12 months prior to surgery.
  3. Patients who have any habits that might jeopardize the osseointegration process, such as current smokers.
  4. Patients with parafunctional habits that produce overload on implant, such as bruxism and clenching.
  5. Patients who have inadequate interarch space for the prosthetic part.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: PRF with immediate implants
Immediate implants placed and covered with two prf layers
soft tissue augmentation by prf
ACTIVE_COMPARATOR: palatal pedicle graft
immediate implant placement followed by soft tissue augmentation by oalatal pedicle graft
soft tissue augmentation by palatal pedicle

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pink Esthetic Score
Time Frame: 5 months
photographs
5 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
facial gingival thickness
Time Frame: 5 months
probe
5 months
mid-buccal gingival level
Time Frame: 5 months
probe
5 months
interproximal gingival level
Time Frame: 5 months
probe
5 months
- width of keratinized gingiva (KG
Time Frame: 5 months
probe
5 months
Crestal bone loss
Time Frame: 5 months
CBCT
5 months
Implant stability
Time Frame: 5 months
ostel
5 months
Pain
Time Frame: 5 months
VAS
5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

December 1, 2017

Primary Completion (ANTICIPATED)

September 1, 2018

Study Completion (ANTICIPATED)

October 1, 2018

Study Registration Dates

First Submitted

July 12, 2017

First Submitted That Met QC Criteria

July 19, 2017

First Posted (ACTUAL)

July 21, 2017

Study Record Updates

Last Update Posted (ACTUAL)

November 7, 2017

Last Update Submitted That Met QC Criteria

November 5, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • Philoprotocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Soft Tissue Augmentation

Clinical Trials on PRF

Subscribe